Skip to main content

HEALTH

  • Walgreens opens employee wellness center in Illinois

  • Biodel receives complete response letter for Linjeta

    DANBURY, Conn. The Food and Drug Administration has turned down an application for an insulin product made by Biodel, Biodel said.

     

    The drug maker announced that it received a complete response letter from the FDA for Linjeta (human insulin [rDNA origin]) for the treatment of Type 1 and Type 2 diabetes.

     

     

  • ResVez sponsors Tasty Awards with help from nutrition bar

    RANCHO SANTA FE, Calif. ResVez on Tuesday announced its sponsorship of the Tasty Awards — a broadcast awards show recognizing the year's best achievements in food and fashion programs on TV, in film and online — making its WineTime bar the “official gourmet nutrition bar.”

     

  • Lilly CEO: 'New approaches' must be found to combat diabetes

    CLEVELAND The CEO of drug maker Eli Lilly has called for a “wave of invention” to combat diabetes.

    Speaking at the Cleveland Clinic Medical Innovation Summit, John Lechleiter said breakthroughs against the disease are needed as urgently today as a century ago, noting that the disease could create a “health and economic time bomb,” as 1-in-3 Americans are forecasted to have the disease by 2050.

     

  • Brioschi Pharmaceuticals to revitalize Brioschi heartburn-relief brand

    FAIR LAWN, N.J. Brioschi Pharmaceuticals International last month announced its intent to revitalize the Brioschi heartburn-relief brand. The company is pitting substantial capital into a marketing plan that incorporates everything from trade promotions, sampling and healthcare professional recommendations to newspaper advertising, digital marketing and sponsorships, the company stated.

     

  • Prestige Brands completes purchase of Blacksmith Brands

    IRVINGTON, N.Y. Prestige Brands Holdings on Monday announced that it has completed its previously announced purchase of Blacksmith Brands Holdings.

     

    The transaction was finalized under the original terms announced on Sept. 20, which called for Prestige to pay $190 million in cash at closing plus a customary working capital adjustment that amounted to $13.4 million.

     

  • Wegmans introduces co-branded glucose monitoring system with Nipro

    ROCHESTER, N.Y. Wegmans on Monday announced the availability of its co-branded blood-glucose monitoring systems: Nipro Diagnostics’ TrueResult system and True2go.

     

  • Hyland's looks to have reformulated teething tablets back on the market in 2011

    LOS ANGELES Hyland’s plans to have a reformulated Teething Tablets product back on the market in early 2011, the company stated, following the initiation of its voluntary recall of the product last week.

     

Related Topics

X
This ad will auto-close in 10 seconds